Codexis

Codexis Gross Profit

The Gross Profit of Codexis (CDXS) as of Oct 20, 2026 is 61.05 M USD. In the previous year, Gross Profit was 43.06 M USD — a change of 41.79% (higher).

Gross Profit

61.05 MUSD

YoY

41.79%

Last updated:

Gross Profit of Codexis is 2025 61.05 M USD. Gross Profit of Codexis was 2024 43.06 M USD. It decreases by 41.79% higher compared to the previous year.

The Codexis Gross Profit history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Profit
Date
Gross Profit
Jan 1, 2018
47.97 M USD
Jan 1, 2019
52.83 M USD
Jan 1, 2020
55.31 M USD
Jan 1, 2021
82.55 M USD
Jan 1, 2022
100.56 M USD
Jan 1, 2023
57.33 M USD
Jan 1, 2024
43.06 M USD
Jan 1, 2025
61.05 M USD
The Codexis Gross Profit history
YEARGross ProfitYoY
61.05 MUSD+41.79%
43.06 MUSD-24.90%
57.33 MUSD-42.98%
100.56 MUSD+21.82%
82.55 MUSD+49.23%
55.31 MUSD+4.71%
52.83 MUSD+10.11%
47.97 MUSD+34.39%
35.70 MUSD-8.67%
39.08 MUSD+10.98%
35.22 MUSD+37.67%
25.58 MUSD+47.29%
17.37 MUSD-69.87%
57.65 MUSD-29.77%
82.08 MUSD+3.74%
79.12 MUSD+19.47%
66.23 MUSD+77.61%
37.29 MUSD+119.17%
17.01 MUSD+64.85%
10.32 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Codexis Revenue

Codexis Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
70.14 M USD
-68.07 M USD
-76.24 M USD
Jan 1, 2024
59.35 M USD
-58.52 M USD
-65.28 M USD
Jan 1, 2025
70.39 M USD
-41.74 M USD
-43.97 M USD
Jan 1, 2026 (e)
73.89 M USD
-31.58 M USD
-33.93 M USD
Jan 1, 2027 (e)
87.69 M USD
-19.61 M USD
-24.99 M USD
Jan 1, 2028 (e)
111.15 M USD
-3.62 M USD
-10.24 M USD
Jan 1, 2029 (e)
139.17 M USD
9.33 M USD
6.32 M USD
Jan 1, 2030 (e)
166.07 M USD
22.56 M USD
17.16 M USD

Codexis Margins

Codexis stock margins

The Codexis margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Codexis. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Codexis.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
81.74 %
-97.04 %
-108.69 %
Jan 1, 2024
72.55 %
-98.61 %
-109.99 %
Jan 1, 2025
86.73 %
-59.30 %
-62.47 %
Jan 1, 2026 (e)
86.73 %
-42.74 %
-45.93 %
Jan 1, 2027 (e)
86.73 %
-22.37 %
-28.50 %
Jan 1, 2028 (e)
86.73 %
-3.26 %
-9.21 %
Jan 1, 2029 (e)
86.73 %
6.70 %
4.54 %
Jan 1, 2030 (e)
86.73 %
13.59 %
10.33 %

Codexis Stock analysis

What does Codexis do? Codexis Inc. is an American biotechnology company that specializes in developing innovative biological solutions for a variety of industries. The company was founded in 2002 and is headquartered in Redwood City, California. Business Model: Codexis is service-oriented and provides customized enzyme solutions for companies looking to improve their products through sustainable processes. The company has developed a unique platform called Rational Protein Engineering, which allows for the development of specific enzymes for various industries. Customers benefit from enzyme optimization expertise and know-how. Divisions: Codexis operates in the fields of life sciences, materials science, agrochemicals, and biofuels. 1. Life Sciences: Codexis specializes in the production of enzymes and biocatalysts for the pharmaceutical industry in the life sciences division. The goal is to provide a faster and more efficient manufacturing process for pharmaceutical active ingredients. The company has successfully developed active ingredients for antibodies, lipids, uric acid, and antivirals. 2. Materials Science: In the materials science division, Codexis specializes in the production of enzymes for materials such as dyes, polymers, and cosmetic products. Codexis ensures that these products are efficiently manufactured without the use of environmentally harmful chemicals. 3. Agrochemicals: Codexis offers customized enzyme solutions to agrochemical manufacturers that reduce the use of chemicals and benefit the environment. These enzymes help in the production of pesticides and other agrochemicals. 4. Biofuels: In the biofuels division, Codexis specializes in the production of enzymes for processing corn, harvested plants, or waste products. These enzymes help enable cost-effective biofuel production. Products: Codexis has developed a wide range of products tailored to the needs of various industries. Some of the products recently introduced to the market by Codexis include: 1. CodeEvolver: CodeEvolver is a platform that allows biotechnology companies to quickly create customized enzyme solutions for their specific needs. The process is fully automated and results in a significant reduction in development time and costs. 2. Codex® screening panels: Codexis offers various screening panels that allow customers to quickly and efficiently select the enzymes best suited for their purposes. The panels are suitable for industries including pharmaceuticals, chemicals, and plant protection. 3. Codex® enzymes: Codexis offers a wide range of enzymes specifically designed for different industry needs. This includes enzymes for the production of biofuels, pesticides, cosmetic products, and pharmaceuticals. Overall, Codexis Inc. has demonstrated its ability to deepen the understanding of biocatalysts and introduce innovative biological processes in a variety of industries through its unique Rational Protein Engineering platform. Codexis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Codexis stock

Gross Profit of Codexis is 61.05 M USD in 2025.

Gross Profit of Codexis changed from 43.06 M USD to 61.05 M USD, representing a 41.79% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Profit Codexis since 2006 – with annual values, charts, and detailed analysis.

Gross Profit is the revenue remaining after deducting the cost of goods sold. It shows how efficiently a company uses its resources to produce goods or services.

Gross Profit's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Gross Profit's Codexis historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Codexis

All Key Metrics — Codexis